Radiation-recall dermatitis with docetaxel: Establishment of a requisite radiation threshold
- 1 April 1997
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 33 (4), 698-699
- https://doi.org/10.1016/s0959-8049(96)00461-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.Journal of Clinical Oncology, 1995
- Radiation-recall dermatitis in a patient treated with paclitaxel.Journal of Clinical Oncology, 1995
- Docetaxel and radiation-recall severe mucositisAnnals Of Oncology, 1994
- Paclitaxel and radiation-recall dermatitis.Journal of Clinical Oncology, 1994
- Taxol: A novel radiation sensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1992
- The “recall effect” in radiotherapy: Is subeffective, reparable damage involved?International Journal of Radiation Oncology*Biology*Physics, 1990
- Radiation Recall Supraglottitis: A Hazard in Head and Neck ChemotherapyJAMA Otolaryngology–Head & Neck Surgery, 1984
- The effect of adriamycin and actinomycin D on radiation-induced skin reactions in mouse feetInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Adriamycin Activating a Recall Phenomenon After Radiation TherapyAnnals of Internal Medicine, 1974
- Potentiation of X-Ray Effects by Actinomycin DRadiology, 1959